About
Insulet Corporation is a medical device company based in Acton, Massachusetts, founded in 2000. The company focuses on improving the lives of people with diabetes by simplifying insulin delivery through advanced technology. Its flagship product is the Omnipod Insulin Management System, a tubeless and disposable insulin pump that provides continuous insulin delivery without traditional tubing. The Omnipod system has evolved over the years, starting with the original version cleared by the FDA in 2005. The Omnipod DASH system, introduced in 2018, features a Personal Diabetes Manager for easier control. In 2022, Insulet launched the Omnipod 5 Automated Insulin Delivery System, which integrates with continuous glucose monitoring technology to automatically adjust insulin delivery. Insulet's products are available in 25 countries, targeting individuals with insulin-dependent diabetes and their caregivers, enhancing convenience and quality of life. The company is committed to innovation and improving diabetes care standards globally.
Technologies
Keywords
Company Information
-
Employees 3900
-
Founded 2000
-
Annual Revenue $2071600000
Location
100 Nagog Park, Acton, Massachusetts, United States, 01720
